½ÃÀ庸°í¼­
»óǰÄÚµå
1595138

»ê¼ÒÄ¡·á±â ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Oxygen Therapy Devices Market by Product (Oxygen Delivery Devices, Oxygen Source Equipment), Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis & Pneumonia), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»ê¼ÒÄ¡·á±â ½ÃÀåÀº 2023³â¿¡ 25¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 27¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 6.78%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 40¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

»ê¼ÒÄ¡·á±â´Â »ê¼Ò¸¦ È¿À²ÀûÀ¸·Î ¼·ÃëÇϰųª Ȱ¿ëÇÏ´Â ´É·ÂÀÌ ¼Õ»óµÈ È£Èí±â ÁúȯÀ» ¾Î°í Àִ ȯÀÚ¿¡°Ô º¸Á¶ »ê¼Ò¸¦ °ø±ÞÇϱâ À§ÇØ ¼³°èµÈ ÀÇ·á ½Ã½ºÅÛÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ¿¡´Â COPD, Æó·Å, ¼ö¸é¹«È£ÈíÁõ°ú °°Àº ±Þ¼º ¹× ¸¸¼º ÁúȯÀ» À§ÇÑ °íÁ¤½Ä ¹× ÈÞ´ë¿ë ¿ëµµ¸¦ À§ÇÑ ³óÃà±â, ¾ÐÃà °¡½º ½Ã½ºÅÛ, ¾×ü ½Ã½ºÅÛ, CPAP ÀåÄ¡¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀåºñÀÇ Çʿ伺Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, Àα¸ °í·ÉÈ­, È£Èí±â °Ç°­¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿À¿° ¼öÁØ Áõ°¡·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ë ºÐ¾ß¿¡´Â º´¿ø, ÀçÅÃÄ¡·á ¹× Àü¹® Ŭ¸®´ÐÀÌ Æ÷ÇԵǸç, ÀçÅà ġ·á¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼±È£µµ Áõ°¡¿Í ÀåºñÀÇ È޴뼺°ú È¿À²¼ºÀ» ³ôÀÌ´Â ±â¼ú ¹ßÀüÀÌ ±× ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 25¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 27¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 40¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 6.78%

ÃÖ±Ù ½ÃÀå ¼ºÀåÀº ¼ÒÇü °íÈ¿À² ±â±â µî ±â¼ú ¹ßÀü, È£Èí±â Áúȯ ¹ßº´·ü Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡¿¡ µû¸¥ ¿µÇâÀÌ Å®´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ ºü¸£°Ô °³¼±µÇ°í È£Èí±â °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â ½ÅÈï ½ÃÀå¿¡ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº IoT¿Í AI¸¦ ÅëÇÕÇÏ¿© ÀåºñÀÇ ±â´É°ú ȯÀÚ ¸ð´ÏÅ͸µÀ» °³¼±ÇÏ´Â µ¥ ÁýÁßÇÔÀ¸·Î½á ÀÌÀÍÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¿¡µµ ºÒ±¸Çϰí, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, »óȯ ¹®Á¦, Á¦Ç° ºñ¿ë »ó½Â µîÀÇ ¹®Á¦°¡ ½ÃÀå ¹ßÀüÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ »ê¼ÒÄ¡·á Àåºñ¿¡ ´ëÇÑ È¯ÀÚ¿Í ÀÇ·áÁøÀÇ ÀνÄÀÌ ¿©ÀüÈ÷ ºÎÁ·ÇÏ¿© ÃÖÀûÀÇ µµÀÔ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ħÅõ¸¦ ±Ø´ëÈ­Çϱâ À§ÇÑ ±ÇÀå»çÇ×À¸·Î´Â ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ÈÞ´ë¿ë ±â±âÀÇ °³¹ß°ú ¼­ºñ½º ¼Ò¿Ü Áö¿ªÀ¸·ÎÀÇ ¼­ºñ½º È®´ë¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀ» À§ÇÑ °¡Àå ÁÁÀº ºÐ¾ß´Â °Ç°­ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°úÀÇ ±â±â ¿¬°á °­È­¿Í ¿¡³ÊÁö È¿À²¼º Çâ»óÀÔ´Ï´Ù. ÀÇ·á¿Í ±â¼úÀÇ ºñ¾àÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇØ ¿ªµ¿ÀûÀÎ ½ÃÀå Æ¯¼º»ó °æÀï·ÂÀ» À¯ÁöÇϱâ À§Çؼ­´Â ²÷ÀÓ¾ø´Â Çõ½Å°ú º¯È­ÇÏ´Â ÀÇ·á ¼ö¿ä¿¡ ´ëÇÑ ´ëÀÀÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇϰí ÀÎ½Ä °³¼± Ä·ÆäÀο¡ ÅõÀÚÇÏ´Â °ÍÀº ½ÃÀåÀÇ ¼ºÀå°ú È®»êÀ» ´õ¿í È®½ÇÇÏ°Ô ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â »ê¼ÒÄ¡·á±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

»ê¼ÒÄ¡·á±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º È£Èí±â Áúȯ Áõ°¡
    • °Ç°­ÇÏÁö ¸øÇÑ »ýȰ½À°üÀÇ È®»ê°ú ³ëÀÎ Àα¸ Áõ°¡
    • ÈÞ´ë¿ë ³óÃà±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °ú¿ë¿¡ ÀÇÇÑ »ê¼Ò Áßµ¶
  • ½ÃÀå ±âȸ
    • ÀçÅà ¿ä¾ç ȯ°æÀ¸·ÎÀÇ È®»ê
    • COVID-19 ȯÀÚ ±ÞÁõ
  • ½ÃÀå °úÁ¦
    • È­Àç ¹× Æø¹ß À§Ç輺

Portre's Five Forces: »ê¼ÒÄ¡·á±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »ê¼ÒÄ¡·á±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »ê¼ÒÄ¡·á±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® »ê¼ÒÄ¡·á±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

»ê¼ÒÄ¡·á±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º »ê¼ÒÄ¡·á±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »ê¼ÒÄ¡·á±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

»ê¼ÒÄ¡·á±â ½ÃÀå¿¡¼­ÀÇ ¼º°ø Àü·« ºÐ¼® ¹× Ãßõ »ê¼ÒÄ¡·á±â ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸®´Ù.

»ê¼ÒÄ¡·á±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå »ê¼ÒÄ¡·á±â ½ÃÀå : Á¦Ç°º°

  • »ê¼Ò °ø±Þ Àåºñ
  • »ê¼Ò¿ø Àåºñ

Á¦7Àå »ê¼ÒÄ¡·á±â ½ÃÀå : ¿ëµµº°

  • õ½Ä
  • ¸¸¼º Æó¼â¼º ÆóÁúȯ
  • ³¶Æ÷¼º ¼¶À¯Áõ ¹× Æó·Å
  • Æó¼â¼º ¼ö¸é¹«È£Èí
  • È£Èí°ï¶õ ÁõÈıº

Á¦8Àå »ê¼ÒÄ¡·á±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø
  • ÀÇ»ç ¿ÀÇǽº

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ »ê¼ÒÄ¡·á±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ê¼ÒÄ¡·á±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »ê¼ÒÄ¡·á±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • BPL Medical Technologies
  • CAIRE Inc.
  • Camozzi Automation S.p.A.
  • Chart Industries, Inc.
  • Drive DeVilbiss International
  • GCE Group
  • Inogen, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Linde plc
  • NGK SPARK PLUG CO.,LTD
  • Nidek Medical Products Inc.
  • O2 Concepts, LLC
  • SMC Corporation of America
  • Supera Anesthesia Innovations
  • Teijin Limited
LSH

The Oxygen Therapy Devices Market was valued at USD 2.55 billion in 2023, expected to reach USD 2.73 billion in 2024, and is projected to grow at a CAGR of 6.78%, to USD 4.05 billion by 2030.

Oxygen therapy devices are medical systems designed to provide supplemental oxygen to patients suffering from respiratory conditions that impair the body's ability to efficiently intake or utilize oxygen. The scope and definition of this market encompass a range of products including concentrators, compressed gas systems, liquid systems, and CPAP devices, catered to both stationary and portable applications for acute and chronic conditions such as COPD, pneumonia, and sleep apnea. The necessity of these devices arises from the increasing prevalence of respiratory disorders, aging populations, and an uptick in pollution levels affecting respiratory health. End-use sectors include hospitals, home healthcare, and specialized clinics, driven by increasing patient preference for home-based care and technological advancements enhancing the portability and efficiency of the devices.

KEY MARKET STATISTICS
Base Year [2023] USD 2.55 billion
Estimated Year [2024] USD 2.73 billion
Forecast Year [2030] USD 4.05 billion
CAGR (%) 6.78%

Recent market growth is predominantly influenced by technological advancements such as compact, high-efficiency devices, the rising incidence of respiratory conditions, and increasing healthcare expenditure. Potential opportunities lie in emerging markets, where healthcare infrastructure is improving rapidly and there is increased awareness of respiratory care. Manufacturers could benefit from focusing on the integration of IoT and AI, which improve device functionality and patient monitoring. Despite these opportunities, challenges such as stringent regulatory frameworks, reimbursement issues, and high product costs can hinder market progress. Furthermore, patient and provider awareness about different oxygen therapy devices is still growing, sometimes affecting optimal adoption.

Recommendations for maximizing market penetration include focusing on developing cost-effective, user-friendly portable devices and expanding services to underserved regions. The best areas for innovation involve enhancing device connectivity with health monitoring systems and improving energy efficiency. The nature of this market is dynamic, with an evolving landscape driven by medical and technological breakthroughs, maintaining a competitive edge requires constant innovation and responsiveness to changing healthcare needs. Fostering partnerships with healthcare providers and investing in awareness campaigns could further solidify market growth and adoption.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oxygen Therapy Devices Market

The Oxygen Therapy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in several chronic respiratory diseases
    • Growing adoption of unhealthy lifestyle & rising geriatric population
    • Rising demand for portable concentrators
  • Market Restraints
    • Overuse can cause the oxygen toxicity
  • Market Opportunities
    • Penetration across homecare settings
    • Rapidly increasing COVID-19 patients
  • Market Challenges
    • Risk of fire and explosion hazards

Porter's Five Forces: A Strategic Tool for Navigating the Oxygen Therapy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oxygen Therapy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oxygen Therapy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oxygen Therapy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oxygen Therapy Devices Market

A detailed market share analysis in the Oxygen Therapy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oxygen Therapy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oxygen Therapy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oxygen Therapy Devices Market

A strategic analysis of the Oxygen Therapy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxygen Therapy Devices Market, highlighting leading vendors and their innovative profiles. These include BPL Medical Technologies, CAIRE Inc., Camozzi Automation S.p.A., Chart Industries, Inc., Drive DeVilbiss International, GCE Group, Inogen, Inc., Invacare Corporation, Koninklijke Philips N.V., Linde plc, NGK SPARK PLUG CO.,LTD, Nidek Medical Products Inc., O2 Concepts, LLC, SMC Corporation of America, Supera Anesthesia Innovations, and Teijin Limited.

Market Segmentation & Coverage

This research report categorizes the Oxygen Therapy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Oxygen Delivery Devices and Oxygen Source Equipment.
  • Based on Application, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis & Pneumonia, Obstructive Sleep Apnea, and Respiratory Distress Syndrome.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Home Care Settings, Hospitals, and Physician Offices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in several chronic respiratory diseases
      • 5.1.1.2. Growing adoption of unhealthy lifestyle & rising geriatric population
      • 5.1.1.3. Rising demand for portable concentrators
    • 5.1.2. Restraints
      • 5.1.2.1. Overuse can cause the oxygen toxicity
    • 5.1.3. Opportunities
      • 5.1.3.1. Penetration across homecare settings
      • 5.1.3.2. Rapidly increasing COVID-19 patients
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of fire and explosion hazards
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oxygen Therapy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Oxygen Delivery Devices
  • 6.3. Oxygen Source Equipment

7. Oxygen Therapy Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. Chronic Obstructive Pulmonary Disease
  • 7.4. Cystic Fibrosis & Pneumonia
  • 7.5. Obstructive Sleep Apnea
  • 7.6. Respiratory Distress Syndrome

8. Oxygen Therapy Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Home Care Settings
  • 8.4. Hospitals
  • 8.5. Physician Offices

9. Americas Oxygen Therapy Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oxygen Therapy Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oxygen Therapy Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BPL Medical Technologies
  • 2. CAIRE Inc.
  • 3. Camozzi Automation S.p.A.
  • 4. Chart Industries, Inc.
  • 5. Drive DeVilbiss International
  • 6. GCE Group
  • 7. Inogen, Inc.
  • 8. Invacare Corporation
  • 9. Koninklijke Philips N.V.
  • 10. Linde plc
  • 11. NGK SPARK PLUG CO.,LTD
  • 12. Nidek Medical Products Inc.
  • 13. O2 Concepts, LLC
  • 14. SMC Corporation of America
  • 15. Supera Anesthesia Innovations
  • 16. Teijin Limited
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦